Related Experiment Videos
Cortical glucose metabolism in Huntington's disease
W R Martin1, C Clark, W Ammann
1Department of Medicine (Neurology), University of Alberta, Edmonton, Canada.
Neurology
|January 1, 1992
Summary
Huntington's disease (HD) shows early frontal lobe metabolism decline. This suggests widespread brain changes, not just basal ganglia, contribute to HD symptoms.
Area of Science:
- Neuroscience
- Neurology
- Medical Imaging
Background:
- Huntington's disease (HD) is a progressive neurodegenerative disorder.
- Basal ganglia pathology is traditionally considered the primary driver of HD symptoms.
Purpose of the Study:
- To investigate cortical glucose metabolism in patients with Huntington's disease.
- To determine if early HD involves widespread cortical dysfunction.
Main Methods:
- Positron emission tomography (PET) was used to measure brain glucose metabolism.
- 39 patients with HD and 34 healthy controls were included in the study.
Main Results:
- Patients with HD for <5 years showed a 15% metabolism decrease in frontal and inferior parietal cortex.
- Patients with HD for >5 years exhibited 25-30% lower metabolism across most cortical areas (except temporal).
Conclusions:
- Early Huntington's disease involves diffuse cortical dysfunction, particularly in frontal lobes.
- Clinical manifestations of HD may stem from broader cortical changes beyond basal ganglia pathology.